Abstract
Decellularized tissues have proven to be versatile matrices for the engineering of tissues and organs. These matrices usually consist of collagens, matrix-specific proteins, and a set of largely undefined growth factors and signaling molecules. Although several decellularized tissues have found their way to clinical applications, their use in the engineering of cartilage tissue has only been explored to a limited extent. We set out to generate hydrogels from several tissue-derived matrices, as hydrogels are the current preferred cell carriers for cartilage repair. Equine cartilage, meniscus, and tendon tissue was harvested, decellularized, enzymatically digested, and functionalized with methacrylamide groups. After photo-cross-linking, these tissue digests were mechanically characterized. Next, gelatin methacrylamide (GelMA) hydrogel was functionalized with these methacrylated tissue digests. Equine chondrocytes and mesenchymal stromal cells (MSCs) (both from three donors) were encapsulated and cultured in vitro up to 6 weeks. Gene expression (COL1A1, COL2A1, ACAN, MMP-3, MMP-13, and MMP-14), cartilage-specific matrix formation, and hydrogel stiffness were analyzed after culture. The cartilage, meniscus, and tendon digests were successfully photo-cross-linked into hydrogels. The addition of the tissue-derived matrices to GelMA affected chondrogenic differentiation of MSCs, although no consequent improvement was demonstrated. For chondrocytes, the tissue-derived matrix gels performed worse compared to GelMA alone. This work demonstrates for the first time that native tissues can be processed into crosslinkable hydrogels for the engineering of tissues. Moreover, the differentiation of encapsulated cells can be influenced in these stable, decellularized matrix hydrogels.
Original language | English |
---|---|
Pages (from-to) | 1195-1206 |
Number of pages | 12 |
Journal | Tissue Engineering. Part A |
Volume | 21 |
Issue number | 7-8 |
DOIs | |
Publication status | Published - 1 Apr 2015 |
Funding
The authors would like to thank Karin van Leersum and Trudy van Ruiten for their assistance in the experimental work. The antibody against collagen type II (II-II6B3), developed by T.F Linsenmayer, was obtained from the DSHB developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242. J.V. was supported by a grant from the Dutch government to the Netherlands Institute for Regenerative Medicine (NIRM, Grant No. FES0908) and J.M. was supported by the Dutch Arthritis Foundation.
Keywords
- MESENCHYMAL STEM-CELLS
- GELATIN METHACRYLATE HYDROGELS
- MULTIPOTENT STROMAL CELLS
- EXTRACELLULAR-MATRIX
- IN-VITRO
- ARTICULAR-CARTILAGE
- COLLAGEN TYPE
- CHONDROGENIC DIFFERENTIATION
- CANINE CHONDROCYTES
- BONE REGENERATION